🇺🇸 FDA
Pipeline program

anti-thymocyte globulin

199/15106

Unknown small_molecule active

Quick answer

anti-thymocyte globulin for Chediak-Higashi Syndrome is a Unknown program (small_molecule) at Ultragenyx Pharmaceutical with 1 ClinicalTrials.gov record(s).

Program details

Company
Ultragenyx Pharmaceutical
Indication
Chediak-Higashi Syndrome
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials